Thursday, May 29, 2025

Closing the Book on Maryland's HIV Criminalization Law

›
By:  Ranier Simons , ADAP Blog Guest Contributor Science and equity slowly continue to push policy forward. On May 21, 2025, Maryland became...
Thursday, May 22, 2025

Is Trump's Executive Order on Most Favored Nations Drug Pricing a Wet Noodle?

›
By:  Ranier Simons , ADAP Blog Guest Contributor, and  Marcus J. Hopkins , ADAP 340B Consultant The Trump Administration’s policies continue...
Thursday, May 15, 2025

Sen. Cassidy Shines Spotlight on 340B Program, Furthering Calls for Reform

›
By:  Ranier Simons , ADAP Blog Guest Contributor, and Marcus J. Hopkins , ADAP 340B Consultant So far in 2025, state legislatures nationwide...
Thursday, May 8, 2025

United States' HIV Viral Suppression Complemented by State AIDS Drug Assistance Programs

›
By:  Ranier Simons , ADAP Blog Guest Contributor Population health decisions should always be evidence-based and informed by quality data. S...
Thursday, May 1, 2025

Trump's Executive Order on Drug Prices Includes Both Good and Bad Ideas

›
By:  Ranier Simons , ADAP Blog Guest Contributor On April 15, 2025, President Donald J. Trump signed Executive Order 14273: Lowering Drug Pr...
Thursday, April 24, 2025

HRSA Mired in Uncertainty, Instability, and Confusion; Patient Advocates Increasingly Concerned

›
By:  Ranier Simons , ADAP Blog Guest Contributor The Trump Administration's developing policies regarding population health and well-bei...
Thursday, April 17, 2025

Why Is the 340B Drug Pricing Program the Next ‘Too Big to Fail’

›
Read the full policy paper, “ Is the 340B Drug Pricing Program the Next ‘Too Big to Fail’? ” By:  Brandon M. Macsata , CEO, ADAP Advocacy Th...